C-D5PTCirculate Health
therapeutic plasma exchange, longevity care, outcomes tracking
clinical care
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-D5PT
C-D5PTC-D5PTtherapeutic plasma exchange, longevity care, outcomes tracking
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Circulate Health therapeutic plasma exchange, longevity care, outcomes tracking
Circulate Health partners with clinics to deliver therapeutic plasma exchange as a fully supported clinical service. The company says TPE separates and replaces plasma to reduce inflammatory and age-related factors in blood. Its clinical work includes standardized protocols, outcomes tracking, ongoing research, and a clinical trial published in Aging Cell reporting an average 2.6-year biological age reduction after six TPE sessions.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Circulate Health — Far from goals · Bottom quartile. Derived deterministically from 2 extracted project(s). Most-advanced status: undisclosed. Band: far. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic